Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval Express Diagnostics Int’l today announced that it has received Health Canada Class III approval to market and sell its DrugCheck® NxStep Onsite Drug Screen Cup in Canada. The urinalysis screening device received Class III approval for 24 different drugs and detection levels, including cotinine (nicotine), EDDP, K2/spice (synthetic marijuana), ketamine, and alcohol. (PRWeb June 19, 2013) Read the ...
June 19, 2013 - PRWeb
Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval Express Diagnostics Int’l today announced that it has received Health Canada Class III approval to market and sell its DrugCheck® NxStep Onsite Drug Screen Cup in Canada. The urinalysis screening device received Class III approval for 24 different drugs and detection levels, including cotinine (nicotine), EDDP, K2/spice (synthetic marijuana), ketamine, and alcohol. (PRWeb June 19, 2013) Read the ...
June 19, 2013 - PRWeb